PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: EAP treatment completed and Orphan Status achieved for MPS-I, page-30

  1. 972 Posts.
    lightbulb Created with Sketch. 216
    Last NFL patient received final dose 23/03. Follow up scan and pain measurements conducted after 6 weeks. Guess what........ We now have all the data from the FDA EAP. Shouldn't take long to collate and release to the market. They say first 5 released this quarter, I feel the full report will be released this quarter.

    DYOR

    PharmD
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.